Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 084853
Company: WATSON LABS
Company: WATSON LABS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
CHLOROTHIAZIDE W/ RESERPINE | CHLOROTHIAZIDE; RESERPINE | 250MG;0.125MG | TABLET;ORAL | Discontinued | None | No | No |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
12/19/1986 | SUPPL-37 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/06/1983 | SUPPL-34 | Manufacturing (CMC) |
Label is not available on this site. |